Herbert Abramson - Announcement - Acquisition of Common Shares of Lorus Therapeutics Inc.

    TORONTO, Nov. 15 /CNW/ - Mr. Herbert Abramson, a Director of Lorus
Therapeutics Inc. ("Lorus"), announces that he has acquired directly or
indirectly, 4,257,525 common shares of Lorus (including common stock options
exercisable into 50,000 common shares), representing 2.0% of the issued and
outstanding common shares.
    Abramson now owns directly or indirectly 25,946,625 common shares and
common stock options exercisable into 50,000 common shares. Assuming the
exercise of these options, Abramson would own 25,996,625 common shares,
representing approximately 12.2% of the then issued and outstanding common
    Mr. Abramson has acquired the securities of Lorus for investment
purposes. Mr. Abramson reserves the right to acquire further securities of
Lorus depending on market conditions and other relevant factors.
    The common shares of Lorus trade on the Toronto Stock Exchange.
    An early warning report in respect of the above noted transactions will
be filed on SEDAR. A copy of this report and further information can be
obtained from:

    Herbert Abramson
    Tel: (416) 956-9334
    Fax: (416) 867-9771

For further information:

For further information: Herbert Abramson, Tel: (416) 956-9334, Fax:
(416) 867-9771

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890